Xu et al. ([1][1]) investigated the actual frequency and clinical outcomes of primary aldosteronism (PA) in newly diagnosed hypertensive patients in China. At least 4% of patients were confirmed to have… Click to show full abstract
Xu et al. ([1][1]) investigated the actual frequency and clinical outcomes of primary aldosteronism (PA) in newly diagnosed hypertensive patients in China. At least 4% of patients were confirmed to have PA, whereas 7% including patients who screened positive but declined confirmatory testing had PA
               
Click one of the above tabs to view related content.